Drug Shortage Report for GALANTAMINE ER
| Report ID | 90894 |
| Drug Identification Number | 02416603 |
| Brand name | GALANTAMINE ER |
| Common or Proper name | GALANTAMINE ER |
| Company Name | PRO DOC LIMITEE |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | GALANTAMINE |
| Strength(s) | 24MG |
| Dosage form(s) | CAPSULE (EXTENDED RELEASE) |
| Route of administration | ORAL |
| Packaging size | 30 |
| ATC code | N06DA |
| ATC description | ANTI-DEMENTIA DRUGS |
| Reason for shortage | Other (Please describe in comments) |
| Anticipated start date | |
| Actual start date | 2019-06-20 |
| Estimated end date | Unknown |
| Actual end date | 2023-07-10 |
| Shortage status | Resolved |
| Updated date | 2023-07-11 |
| Company comments | Discontinued as of July 10, 2023 – Discontinué en date du 10 juillet 2023. |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 2925 BOULEVARD INDUSTRIEL LAVAL, QUEBEC CANADA H7L 3W9 |
| Company contact information | 2925 BOULEVARD INDUSTRIEL, LAVAL QC, H7L 3W9 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v1 | 2019-08-06 | English | Compare |
| v2 | 2019-08-06 | French | Compare |
| v3 | 2023-07-11 | English | Compare |
| v4 | 2023-07-11 | French | Compare |
Showing 1 to 4 of 4